Biotransformation of the Mycotoxin, Zearalenone, to a Non-estrogenic Compound by a Fungal Strain of Clonostachys sp

Bioscience, Biotechnology and Biochemistry

Volumn 66, Issue 12, 2002, Pages 2723-2726

  Kakeya, Hideaki ^a   Takahashi Ando, Naoko ^b   Kimura, Makoto ^b   Onose, Rie ^a   Yamaguchi, Isamu ^b   Osada, Hiroyuki ^a  

^a RIKEN   (Japan)

^b Elements Chemistry Laboratory   (South Korea)

Author keywords

Biotransformation; Detoxification; Microorganisms; Mycotoxins; Zearalenone

Indexed keywords

1 (3,5 DIHYDROXYPHENYL) 10' HYDROXY 1' UNDECENE 6' ONE; 1-(3,5-DIHYDROXYPHENYL)-10'-HYDROXY-1'-UNDECENE-6'-ONE; ESTROGEN; KETONE; RESORCINOL DERIVATIVE; ZEARALENONE;

ARTICLE; ASCOMYCETES; BIOTRANSFORMATION; BREAST TUMOR; CELL CULTURE; CELL DIVISION; CHEMICAL STRUCTURE; CLASSIFICATION; DRUG EFFECT; HUMAN; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

ASCOMYCOTA; BIOTRANSFORMATION; BREAST NEOPLASMS; CELL DIVISION; ESTROGENS; HUMANS; KETONES; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; RESORCINOLS; TUMOR CELLS, CULTURED; ZEARALENONE;

BIONECTRIA OCHROLEUCA; CLONOSTACHYS; FUSARIUM; MINK CELL FOCUS-FORMING VIRUS;

EID: 0042703181     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.66.2723     Document Type: Article

References (22)

1. Mirocha, C. J., Christensen, C. M., and Nelson, G. J., F-2 (zearalennone) estrogenic mycotoxin from Fusarium. In “Microbial Toxins” vol. VII, eds. Kadis, S., Ciegler, A., and Ajl, S. J., Academic Press, New York, pp. 107-138 (1971).
2. Mirocha, C. J., Pathre, S. V., and Christensen, C. M., Zearalenone. In “Mycotoxins in human and animal health”, eds. Rodricks, J. V., Hesseltine, C. W., and Mehlman, M. A., Pathotox Publishers, Park Forest South, IL, pp. 345-364 (1977).
3. Ruddick, J. A., Scott, P. M., and Harwig, J., Terato-logical evaluation of zearalenone administered orally to rat. Bull. Environ. Contam. Toxicol., 15, 678-681 (1976).
4. Hidy, P. H., Baldwin, R. S., Greasham, R. L., Keith, C. L., and McMullen, J. R., Zearalenone and some derivatives: production and biological activities. Adv. Appl. Microbiol., 22, 59-82 (1977).
5. Ghedira-Chekir, L., Maaroufi, K., Creppy, E. E., and Bacha, H., Cytotoxic and genotoxic effects of zearalenone: prevention by vitamin E. J. Toxicol. Toxin Rev., 18, 355-368 (1999).
6. Saenz de Rodriguez, C. A., Bougiovanni, A. M., and Conde de Borrego, L., An epidemic of precocious development in Puerto Rican children. J. Pedatr., 107, 393-396 (1985).
7. Kuiper-Goodman, T., Scott, P. M., and Watanabe, H., Risk assessment of the mycotoxin zearalenone. Reg. Toxicol. Pharmacol., 7, 253-306 (1987).
8. t=14.4min. [detector wave length, 215 nm; column, PEGASIL ODS (4.6 i.d.x 250 mm, Senshu Scientific Co., Tokyo, Japan); solvent, a linear gradient of aetonitrile-water from 20:80 to 100% acetonitrile in 30min.; flow rate, 1 mlzmin].
9. Martin, P. M., Horwitz, K. B., Ryan, D. S., and McGuire, W. L., Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology, 103, 1860-1867 (1978).
10. WErk pathway is essential for the mycoestrogen zearelenone-induced cell-cycle progression in MCF-7 cells. Mol. Carcinog., 30, 88-98 (2001).
11. Kamimura, H., Conversion of zearalenone to zearale-none glycoside by Rhizopus sp. Appl. Environ. Microbiol., 52, 515-519 (1986).
12. El-Sharkawy, S., and Abul-Hajj, Y. J., Microbial transformation of zearalenone. 1. Formation of zearalenone-4-O-b-glucoside. J. Nat. Prod., 50, 520-521 (1987).
13. El-Sharkawy, S., and Abul-Hajj, Y. J., Microbial transformation of zearalenone. 2. Reduction, hydroxylation and methylation products. J. Org. Chem., 53, 515-519 (1988).
14. El-Sharkawy, S., and Abul-Hajj, Y. J., Microbial cleavage of zearalenone. Xenobiotica, 18, 365-371 (1988).
15. Urry, M. H., Wehrmeister, H. L., Hodge, E. B., and Hidy, P. H., The structure of zearalenone. Tetrahedron Lett., 27, 3109-3114 (1966).
16. Hurd, R. N., Structure activity relationships in zearalenones. In “Mycotoxins in human and animal health”, eds. Rodricks, J. V., Hesseltine, C. W., and Mehlman, M. A., Pathotox Publishers, Park Forest South, IL, pp. 379-391 (1977).
17. Shier, W. T., Shier, A. C., Xie, W., and Mirocha, C. J., Structure-activity relationships for human estrogenic activity in zearalenone mycotoxins. Toxicon., 39, 1435-1438 (2001).
18. Takahashi-Ando, N., Kimura, M., Kakeya, H., Osada, H., and Yamaguchi, I., A novel lactono-hydrolase responsible for the detoxification of zearalenone: enzyme purification and gene cloning. Biochem. J., 365, 1-6 (2002).
19. Matsumura, F., Mechanism of action of dioxin-type chemicals, pesticides, and other xenobiotics affecting nutritional indexes. Am. J. Clin. Nutr., 61, 695S-701S (1995).
20. Daston, G. P., Gooch, G. W., Breslin, W. J., Shuey, D. L., Nikiforov, A. I., Fico, T. A., and Gorsuch, J. W., Environmental estrogens and reproductive health: a discussion of the human and environmental data. Reprductive Tox., 11, 465-481 (1997).
21. Ahmed, S. A., The immune system as a potential target for environmental estrogens (endocrine disrupters): a new emerging field. Toxicology, 150, 191-206 (2000).
22. Toi, M., Bicknell, R., and Harris, A. L., Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res., 52, 275-279 (1992).